BCG LIVE for Bladder transitional cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where BCG LIVE was used for Bladder transitional cell carcinoma.
Most Reported Side Effects for BCG LIVE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Bacillus calmette-guerin infection | 11 | 22.9% | 1 | 4 |
| Drug ineffective | 6 | 12.5% | 2 | 1 |
| Bladder cancer recurrent | 5 | 10.4% | 2 | 1 |
| Decreased appetite | 5 | 10.4% | 0 | 1 |
| Dysuria | 5 | 10.4% | 0 | 3 |
| Sepsis | 5 | 10.4% | 2 | 5 |
Other Indications for BCG LIVE
Other Drugs Used for Bladder transitional cell carcinoma
GEMCITABINE (335)
CISPLATIN (252)
PEMBROLIZUMAB (251)
ATEZOLIZUMAB (195)
CARBOPLATIN (146)
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (119)
AVELUMAB (104)
DURVALUMAB (88)
NIVOLUMAB (80)
ENFORTUMAB VEDOTIN-EJFV (68)